No ‘magic bullet’ for coronavirus, experts say

Support us and go ad-free

There is no “magic bullet” to treat coronavirus (Covid-19) and several drugs will probably be needed to tackle the virus, experts have said.

They said repurposing existing medicines is a faster alternative to developing and manufacturing new vaccines.

A team of researchers representing the International Union of Basic and Clinical Pharmacology caution that an effective and scalable vaccine is likely to take more than a year before it can be used to tackle the global pandemic.

Dr Steve Alexander from the University of Nottingham said: “While we’re waiting for a vaccine, drugs currently being used to treat other illnesses can be investigated as treatments for Covid-19 – in other words repurposed.

“There’s unlikely to be a single magic bullet – we will probably need several drugs in our armoury, some that will need to be used in combination with others.

“The important thing is that these drugs are cheap to produce and easy to manufacture. That way, we can ensure access to affordable drugs across the globe, not just for wealthier nations.”

Read on...

Support us and go ad-free
HEALTH Coronavirus
(PA Graphics)

The review, published in the British Journal of Pharmacology, looks at potential therapeutic drug targets – the chinks in the virus’s armour or weak spots in the body’s defences.

Two key targets appear to be proteins on the surface of our cells, to which Sars-CoV-2 binds, allowing it entry – ACE2 and TMPRSS2.

TMPRSS2 appears to be common on cells, whereas ACE2 is usually present at low levels that increase depending on sex, age and smoking history.

Professor Anthony Davenport from the University of Cambridge said: “As we know these two proteins play a role in this coronavirus infection, we can focus on repurposing drugs that already have regulatory approval or are in the late stages of clinical trials.

“These treatments will have already been shown to be safe and so, if they can now be shown to be effective in Covid-19, they could be brought to clinical use relatively quickly.”

He added that any drug would need to focus on the three key stages of infection – preventing the virus entering human cells, stopping it replicating if it gets inside the cells, and reducing damage to tissue.

The team said existing drugs that are effective in clinical trials need to be rapidly identified so patients can be treated as soon as possible.

It said this needs to be done quickly also because cases are likely to fall during the summer, meaning there will be fewer people who can be recruited to clinical trials.

One existing drug being considered is remdesivir – originally developed for Ebola.

Clinical trials in the US have suggested the drug may be beneficial for patients admitted to hospital with Covid-19, and the US Food and Drug Administration has approved it for emergency use.

The experts added that patience was needed in the wait for an effective vaccine.

Dr Alexander said: “Although there are a lot of vaccines being developed around the world, which we hope will be successful, it’s still going to take a long time before those vaccines are shown to be effective and can be manufactured at the scale needed to make an impact.”

Support us and go ad-free

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us